Plain-English translation of NCT07457762 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether working with a pharmacist can help patients with pulmonary arterial hypertension (a rare lung condition affecting blood pressure in the lungs) take their medication — iloprost, an inhaled treatment — more consistently and effectively. The study compares two groups: one that receives pharmacist support and guidance on using the inhaler correctly, and one that receives standard care. The goal is to see if this extra support improves how well patients stick to their treatment and reduces bothersome side effects.
Iloprost is an important medication for this condition, but patients often struggle with it because it requires frequent doses throughout the day and has a specific technique needed to use the inhaler properly. While pharmacist support has been proven helpful in other lung diseases like asthma, it hasn't been well studied in pulmonary arterial hypertension — so this trial aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
Participants will be divided into two groups. One group will meet with a pharmacist who will teach them proper inhaler technique, help them remember to take doses, answer questions about side effects, and support them throughout the study. The other group will receive their usual care without this extra pharmacist support. Both groups will likely have clinic visits to check on their health, and you may be asked to complete a walking test and answer questions about how well you're managing your medication.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Brazil